First Doses of Sputnik V from Torlak in 15 to 20 Days
Illustration (Photo: Pixabay.com/Alexey Fedenkov)

The Russian Nation Research Institute of Epidemiology and Microbiology Gamaleya has confirmed the quality of the vaccine produced at Torlak and approved the production of Sputnik V, and Serbia is the first country in Europe to produce the vaccine.
Popovic said that colleagues from Serbia had had a reception with the director of the Gamaleya Institute and an entire team of experts the day before. They handed them the certificate for the production of the Sputnik V vaccine at Torlak.
He said that, initially, Torlak should produce around 100,000 vaccines and that the first doses could be expected 15 to 20 days later.
Comments
Your comment
Naš izbor
Most Important News
Full information is available only to commercial users-subscribers and it is necessary to log in.
Follow the news, tenders, grants, legal regulations and reports on our portal.
Registracija na eKapiji vam omogućava pristup potpunim informacijama i dnevnom biltenu
Naš dnevni ekonomski bilten će stizati na vašu mejl adresu krajem svakog radnog dana. Bilteni su personalizovani prema interesovanjima svakog korisnika zasebno,
uz konsultacije sa našim ekspertima.